000 | 01812 a2200517 4500 | ||
---|---|---|---|
005 | 20250518012508.0 | ||
264 | 0 | _c20191120 | |
008 | 201911s 0 0 eng d | ||
022 | _a1098-5514 | ||
024 | 7 |
_a10.1128/JVI.01695-18 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNelson, Cody S | |
245 | 0 | 0 |
_aIntrahost Dynamics of Human Cytomegalovirus Variants Acquired by Seronegative Glycoprotein B Vaccinees. _h[electronic resource] |
260 |
_bJournal of virology _c03 2019 |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdjuvants, Immunologic |
650 | 0 | 4 |
_aAntibodies, Neutralizing _ximmunology |
650 | 0 | 4 |
_aAntibodies, Viral _ximmunology |
650 | 0 | 4 |
_aBlood _xvirology |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCytomegalovirus _xclassification |
650 | 0 | 4 |
_aCytomegalovirus Vaccines _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_aRetinal Pigment Epithelium _xcytology |
650 | 0 | 4 |
_aSaliva _xvirology |
650 | 0 | 4 | _aSeroconversion |
650 | 0 | 4 |
_aUrine _xvirology |
650 | 0 | 4 | _aVaccination |
650 | 0 | 4 |
_aVaccines, Subunit _ximmunology |
650 | 0 | 4 |
_aViral Envelope Proteins _ximmunology |
650 | 0 | 4 |
_aViral Load _ximmunology |
700 | 1 | _aVera Cruz, Diana | |
700 | 1 | _aSu, Melody | |
700 | 1 | _aXie, Guanhua | |
700 | 1 | _aVandergrift, Nathan | |
700 | 1 | _aPass, Robert F | |
700 | 1 | _aForman, Michael | |
700 | 1 | _aDiener-West, Marie | |
700 | 1 | _aKoelle, Katia | |
700 | 1 | _aArav-Boger, Ravit | |
700 | 1 | _aPermar, Sallie R | |
773 | 0 |
_tJournal of virology _gvol. 93 _gno. 5 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1128/JVI.01695-18 _zAvailable from publisher's website |
999 |
_c29132254 _d29132254 |